abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeblueskyburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfilterflaggenderglobeglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptriangletwitteruniversalitywebwhatsappxIcons / Social / YouTube

هذه الصفحة غير متوفرة باللغة العربية وهي معروضة باللغة English

رد الشركة

Gilead Sciences did not respond to: Médecins Sans Frontières says prices of essential new AIDS drugs in developing countries are too high.

Gilead Sciences لم ترد على

Prices of AIDS medicines in developing countries continue to be a concern

القصة 28 يونيو 2005

الجدول الزمني